The Ministry of Innovative Development held talks with representatives of the Institute of Microbiology of Chinese Academy of Sciences and Anhui Zhifei Longcom Biopharmaceutical on conducting clinical trials of a recombinant coronavirus vaccine. The vaccine, developed by this company and currently undergoing clinical trials, is an engineering-genetic protein of coronavirus surface antigen and has a…